Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma

HAMID BUR; KIRSI-MARIA HAAPASAARI; TAINA TURPEENNIEMI-HUJANEN; OUTI KUITTINEN; PÄIVI AUVINEN; KATJA MARIN; YLERMI SOINI; PEETER KARIHTALA

Research ArticleClinical Studies

Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma

HAMID BUR, KIRSI-MARIA HAAPASAARI, TAINA TURPEENNIEMI-HUJANEN, OUTI KUITTINEN, PÄIVI AUVINEN, KATJA MARIN, YLERMI SOINI and PEETER KARIHTALA

Anticancer Research January 2018, 38 (1) 329-336;

HAMID BUR

1Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland

2Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KIRSI-MARIA HAAPASAARI

2Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland

3Department of Pathology, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAINA TURPEENNIEMI-HUJANEN

1Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland

2Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

OUTI KUITTINEN

1Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland

2Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

PÄIVI AUVINEN

4Department of Oncology, Kuopio University Hospital, Kuopio, Finland

5Cancer Center, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KATJA MARIN

4Department of Oncology, Kuopio University Hospital, Kuopio, Finland

5Cancer Center, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YLERMI SOINI

2Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland

3Department of Pathology, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland

5Cancer Center, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

6Department of Pathology and Forensic Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

PEETER KARIHTALA

1Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland

2Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: peeter.karihtala{at}oulu.fi

Article
Figures & Data
Info & Metrics
PDF

PreviousNext

In this issue

Anticancer Research

Vol. 38, Issue 1

January 2018

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 1 + 13 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma

HAMID BUR, KIRSI-MARIA HAAPASAARI, TAINA TURPEENNIEMI-HUJANEN, OUTI KUITTINEN, PÄIVI AUVINEN, KATJA MARIN, YLERMI SOINI, PEETER KARIHTALA

Anticancer Research Jan 2018, 38 (1) 329-336;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma

HAMID BUR, KIRSI-MARIA HAAPASAARI, TAINA TURPEENNIEMI-HUJANEN, OUTI KUITTINEN, PÄIVI AUVINEN, KATJA MARIN, YLERMI SOINI, PEETER KARIHTALA

Anticancer Research Jan 2018, 38 (1) 329-336;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

No citing articles found.

Google Scholar

Keywords

hypoxia
HIF
PHD
Hodgkin's lymphoma
prognosis

Main menu

User menu

Search

Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords